Search
Returning search results with filters:
Remove filter for
Issue: Undeclared substance
Remove filter for
Recall class: Type II
Clear all
Type
Audience
Category
Issue
Last updated
Recall class
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archived checkbox.
Displaying 1 - 4 of 4 items.
The affected lots may contain an undeclared ingredient, prostaglandin analogue PGF2α listed on the prescription drug list.
RecallHealth product recall | 2023-06-12
Product sold without market authorization (DIN) in Canada. All affected lots may contain bimatoprost, a prostaglandin analogue, which is listed on the prescription drug list. Test results for Lot 20220331 found the product to contain bimatoprost.…
RecallHealth product recall | 2022-09-26
Presence of isopropyl alcohol in affected lots.
RecallHealth product recall | 2022-07-21
Quality concerns of affected lots due to deficiencies in Good Manufacturing Practices (GMP). May contain undeclared impurity, methanol, at elevated levels.
RecallHealth product recall | 2022-06-16